19 April 2013
Probe Scientific signs major development and non-exclusive licence agreements with A. Menarini Diagnostics. This will allow Menarini to combine Probe’s MicroEye® blood sampling device with their GlucoMenDay® device for continuous glucose monitoring
24 October 2012
Probe Scientific is working closely with BVT technologies to further develop continuous glucose monitoring systems.
24 October 2012
Probe Scientific to take part in European study monitoring immunosuppressants. The €5.2m FP7 funded project features researchers and commercial companies from 6 European counties.
1 October 2012
Probe scientific is pleased to announce the appointment of George Zajicek as Chairman. George brings with him significant diagnostic and phmaceutical industry experience.
8 September 2011
The Board confirmed that it closed an investment round from existing shareholders and directors. This allows Probe to develop new partnerships and applications and allows it to conclude existing licence deals in a range of territories/markets
28 January 2011
Probe held meetings with a number of commercial companies who are interested in using Probe’s technology. Discussions ranged from those interested in specific applications or analytes to those interested in fully integrated multi analyte applications
3 November 2009
Probe's office in the West Midlands is now open.
30 January 2009
Probe has recently completed third party key opinion leader studies in Europe and the USA.
9 November 2007
Probe Scientific has formally launched MicroEye®, a revolutionary device to solve clinical problems and enhance healthcare through more efficient and effective blood sampling.